OP Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.2M Buy
111,197
+62,530
+128% +$25M 0.37% 44
2026
Q2
$18.8M Sell
48,667
-9,889
-17% -$3.67M 0.2% 82
2026
Q1
$17.1M Buy
58,556
+24,182
+70% +$7.95M 0.15% 94
2025
Q4
$12M Buy
34,374
+170
+0.5% +$57.4K 0.15% 115
2025
Q3
$11.1M Sell
34,204
-24,028
-41% -$7.47M 0.15% 115
2025
Q2
$22.6M Buy
58,232
+12,783
+28% +$5.14M 0.33% 46
2025
Q1
$19.8M Buy
+45,449
New +$18.2M 0.33% 49

Other funds holding ELV

OP Asset Management's ELV Position: Q3 2026 in Review

OP Asset Management increased its Elevance Health (ELV) stake by 128% in Q3 2026, buying an estimated $25M and bringing the position to 111,197 shares worth $43.2M. The position accounts for 0.37% of the portfolio, ranked #44.

OP Asset Management first reported a position in ELV in Q1 2025 and has held it in 7 quarters since. 1,625 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • OP Asset Management held 111,197 shares of Elevance Health worth $43.2M as of Q3 2026.
  • OP Asset Management bought 62,530 Elevance Health shares in Q3 2026, an estimated $25M.
  • Elevance Health made up 0.37% of OP Asset Management's portfolio in Q3 2026, its #44 holding.
  • OP Asset Management first reported a position in Elevance Health in Q1 2025 and has held it in 7 quarters since.
  • 1,625 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on OP Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.